Journal of Pediatric Surgery
Volume 42, Issue 1 , Pages 148-152 , January 2007

Neuroblastoma-derived secretory protein messenger RNA levels correlate with high-risk neuroblastoma

  • Sanjeev A. Vasudevan

      Affiliations

    • Division of Pediatric Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX 77030, USA
    • ,
  • Heidi V. Russell

      Affiliations

    • Department of Pediatrics, Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA
    • ,
  • M. Fatih Okcu

      Affiliations

    • Department of Pediatrics, Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA
    • ,
  • Susan M. Burlingame

      Affiliations

    • Division of Pediatric Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX 77030, USA
    • ,
  • Zhiyun J. Liu

      Affiliations

    • Division of Pediatric Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX 77030, USA
    • ,
  • Jianhua Yang

      Affiliations

    • Department of Pediatrics, Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA
    • Corresponding Author InformationCorresponding authors. Jianhua Yang, Texas Children's Hospital, Feigin Center, Rmc. 0730 08, Mail code- MC3-3320,1102 Bates, Houston, TX 77030, USA. Tel.: +1 832 824 4572; fax: +1 832 825 4732.
    • ,
  • Jed G. Nuchtern

      Affiliations

    • Division of Pediatric Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX 77030, USA
    • Department of Pediatrics, Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA
    • Corresponding Author InformationCorresponding authors. Jianhua Yang, Texas Children's Hospital, Feigin Center, Rmc. 0730 08, Mail code- MC3-3320,1102 Bates, Houston, TX 77030, USA. Tel.: +1 832 824 4572; fax: +1 832 825 4732.

References 

  1. Brodeur GM, Maris JM. Neuroblastoma. In:  Pizzo PA,  Poplack DG editor. Principles and practice of pediatric oncology. 4th ed. Philadelphia (Pa): Lippincott Williams & Wilkins; 2002;p. 895–937
  2. Beiske K, Ambros PF, Burchill SA, et al. Detecting minimal residual disease in neuroblastoma patients—the present state of the art. Cancer Lett. 2005;28:229–240
  3. Cheung IY, Sahota A, Cheung NK. Measuring circulating neuroblastoma cells by quantitative reverse transcriptase-polymerase chain reaction analysis. Cancer. 2004;101:2303–2308
  4. Cheung IY, Lo Piccolo MS, Kushner BH, et al. Early molecular response of marrow disease to biologic therapy is highly prognostic in neuroblastoma. J Clin Oncol. 2003;21:3853–3858
  5. Cheung IY, Lo Piccolo MS, Kushner BH, et al. Quantitation of GD2 synthase mRNA by real-time reverse transcriptase polymerase chain reaction: clinical utility in evaluating adjuvant therapy in neuroblastoma. J Clin Oncol. 2003;21:1087–1093
  6. Pagani A, Macri L, Faulkner LB, et al. Detection procedures for neuroblastoma cells metastatic to blood and bone marrow: blinded comparison of chromogranin A heminested reverse transcription polymerase chain reaction to tyrosine hydroxylase nested reverse transcription polymerase chain reaction and to anti-GD2 immunocytology. Diagn Mol Pathol. 2002;11:98–106
  7. Vasudevan SA, Nuchtern JG, Shohet JM. Gene profiling of high risk neuroblastoma. World J Surg. 2005;29:317–324
  8. Cristofanilli M, Budd GT, Ellis MJ, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004;351:781–791
  9. Moreno JG, Miller MC, Gross S, et al. Circulating tumor cells predict survival in patients with metastatic prostate cancer. Urology. 2005;65:713–718
  10. Oberg AN, Lindmark GE, Israelsson AC, et al. Detection of occult tumour cells in lymph nodes of colorectal cancer patients using real-time quantitative RT-PCR for CEA and CK20 mRNAs. Int J Cancer. 2004;111:101–110
  11. Wharton RQ, Jonas SK, Glover C, et al. Increased detection of circulating tumor cells in the blood of colorectal carcinoma patients using two reverse transcription-PCR assays and multiple blood samples. Clin Cancer Res. 1999;5:4158–4163
  12. Jotsuka T, Okumura Y, Nakano S, et al. Persistent evidence of circulating tumor cells detected by means of RT-PCR for CEA mRNA predicts early relapse: a prospective study in node-negative breast cancer. Surgery. 2004;135:419–426
  13. Nebozhyn M, Loboda A, Kari L, et al. Quantitative PCR on 5 genes reliably identifies CTCL patients with 5-99% circulating tumor cells with 90% accuracy. Blood. 2006;107:3189–3196
  14. Santini D, Tonini G, Vincenzi B, et al. Skin lesions in melanoma and Kaposi's sarcoma. Case 1. Detection of circulating malignant cells by RT-PCR in a case of cutaneous melanoma in complete regression. J Clin Oncol. 2002;20:1411–1412
  15. Shimazui T, Yoshikawa K, Uemura H, et al. Detection of cadherin-6 mRNA by nested RT-PCR as a potential marker for circulating cancer cells in renal cell carcinoma. Int J Oncol. 2003;23:1049–1054
  16. De Luca A, Pignata S, Casamassimi A, et al. Detection of circulating tumor cells in carcinoma patients by a novel epidermal growth factor receptor reverse transcription-PCR assay. Clin Cancer Res. 2000;6:1439–1444

 Presented at the 37th Annual Meeting of the American Pediatric Surgical Association, May 20–24, 2006, Hilton Head, SC.

PII: S0022-3468(06)00668-3

doi: 10.1016/j.jpedsurg.2006.09.064

Journal of Pediatric Surgery
Volume 42, Issue 1 , Pages 148-152 , January 2007

Article Tools

* Image Usage & Resolution